Filing Details
- Accession Number:
- 0001048477-23-000037
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-11 13:59:31
- Reporting Period:
- 2023-08-10
- Accepted Time:
- 2023-08-11 13:59:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1197355 | J Henry Fuchs | C/O Biomarin Pharmaceutical Inc. 770 Lindaro St. San Rafael CA 94901 | President, Worldwide R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-08-10 | 12,000 | $90.43 | 176,187 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The price in column 4 is the weighted average price. The price actually received ranged from $90.40 to $90.515. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.